Mclean, United States
Vytal, founded in 2021, is at the forefront of a transformative approach in the field of contemporary medicine by focusing on brain health. Leveraging its slogan, "30-second brain health evaluations: remote, quantitative, and comprehensive," the company aims to revolutionize early detection and ongoing evaluation of brain diseases.
The startup's innovative approach is built around a novel gaze-tracking algorithm designed to assess brain health via ocular biometrics. This technology not only promises the democratization of brain health assessments but also spearheads a new paradigm in neurological diagnostics, aligning with emerging trends in the Health Care and Medical Devices industries.
Headquartered in the United States, Vytal has recently secured a $1.20M Seed investment as of 01 August 2023, marking a significant milestone in its growth and validating its core thesis. As the company progresses, investors should watch closely as it continues to innovate at the intersection of health and technology.
